Retatrutide is a new pharmaceutical in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these receptors, Retatrutide suppresses appetite, {promotesglucose regulation, and ultimately contributes to significant weight loss. While furth